PANews reported on November 10 that, according to Ember, Bitmine (NYSE: BMNR) has a total cost of approximately $4,020 per ETH and currently has a paper loss of approximately $1.66 billion. Earlier today, it was reported that Bitmine increased its holdings by over 110,000 ETH last week, bringing its total holdings to 3.5 million ETH .PANews reported on November 10 that, according to Ember, Bitmine (NYSE: BMNR) has a total cost of approximately $4,020 per ETH and currently has a paper loss of approximately $1.66 billion. Earlier today, it was reported that Bitmine increased its holdings by over 110,000 ETH last week, bringing its total holdings to 3.5 million ETH .
Bitmine's ETH cost was approximately $4,020 per coin, and its current unrealized loss is approximately $1.66 billion.
Per feedback o dubbi su questo contenuto, contattateci all'indirizzo crypto.news@mexc.com.
PANews reported on November 10 that, according to Ember, Bitmine (NYSE: BMNR) has a total cost of approximately $4,020 per ETH and currently has a paper loss of approximately $1.66 billion.
Earlier today, it was reported that Bitmine increased its holdings by over 110,000 ETH last week, bringing its total holdings to 3.5 million ETH .
Disclaimer: gli articoli ripubblicati su questo sito provengono da piattaforme pubbliche e sono forniti esclusivamente a scopo informativo. Non riflettono necessariamente le opinioni di MEXC. Tutti i diritti rimangono agli autori originali. Se ritieni che un contenuto violi i diritti di terze parti, contatta crypto.news@mexc.com per la rimozione. MEXC non fornisce alcuna garanzia in merito all'accuratezza, completezza o tempestività del contenuto e non è responsabile per eventuali azioni intraprese sulla base delle informazioni fornite. Il contenuto non costituisce consulenza finanziaria, legale o professionale di altro tipo, né deve essere considerato una raccomandazione o un'approvazione da parte di MEXC.
Potrebbe anche piacerti
United Health Products Gains FDA Approval for New Clinical Study Plan to Address Warning Letter
United Health Products gets FDA approval for new CelluSTAT gauze clinical study plan with a partner sponsor and a GCP audit to resolve a 2025 Warning Letter. The
Condividi
Citybuzz2026/04/06 20:00
USD/JPY Analysis: Critical Yen Slide and Bank of Japan Policy Risks – BNY Mellon Perspective
BitcoinWorld USD/JPY Analysis: Critical Yen Slide and Bank of Japan Policy Risks – BNY Mellon Perspective TOKYO, March 2025 – The USD/JPY currency pair continues
Condividi
bitcoinworld2026/04/06 19:55
Unexpected Collaborations: North Korean IT Workers in DeFi Projects
The post Unexpected Collaborations: North Korean IT Workers in DeFi Projects appeared on BitcoinEthereumNews.com. Recent claims from a respected on-chain analyst
Condividi
BitcoinEthereumNews2026/04/06 19:59
